top of page
THE ROLE OF JAKAFI IN STEROID-REFRACTORY ACUTE GVHD
Thu, Dec 05
|The Capital Grille
Registration is Closed
See other events
Time & Location
Dec 05, 2019, 5:00 PM – 8:00 PM
The Capital Grille, Hynes Convention Center, 900 Boylston St, Boston, MA 02115, USA
Guests
About The Event
You are cordially invited to attend a program:
THE ROLE OF JAKAFI IN STEROID-REFRACTORY ACUTE GVHD
Presented by:
Paul Larson, MSN, NP
Program Summary:
This promotional presentation will review diagnosis, staging, and grading of acute graft-versus-host disease (GVHD), identification of patients with steroid-refractory acute GVHD, and use of Jakafi® (ruxolitinib), a targeted JAK1/JAK2 inhibitor, for these patients. Data from the REACH1 study will be reviewed, along with important safety information for Jakafi.
bottom of page